Dignitana AB (publ) (DIGN.ST)
SEK 1.97
(3.42%)
SEK 1.97
(3.42%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 7.41 Million SEK | 46.7% |
| 2022 | 5.05 Million SEK | -29.03% |
| 2021 | 7.12 Million SEK | -4.49% |
| 2020 | 7.45 Million SEK | -20.62% |
| 2019 | 9.39 Million SEK | 48.85% |
| 2018 | 6.3 Million SEK | 145.68% |
| 2017 | 2.56 Million SEK | 3.51% |
| 2016 | 2.48 Million SEK | -73.21% |
| 2015 | 9.26 Million SEK | 187.67% |
| 2014 | 3.21 Million SEK | -41.21% |
| 2013 | 5.47 Million SEK | -9.1% |
| 2012 | 6.02 Million SEK | -32.54% |
| 2011 | 8.92 Million SEK | 68.74% |
| 2010 | 5.29 Million SEK | 108.14% |
| 2009 | 2.54 Million SEK | -12.8% |
| 2008 | 2.91 Million SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 10.64 Million SEK | 43.59% |
| 2024 Q2 | 14.13 Million SEK | 32.81% |
| 2023 Q1 | 5.18 Million SEK | 2.59% |
| 2023 Q3 | 5.53 Million SEK | 11.65% |
| 2023 FY | 7.41 Million SEK | 46.7% |
| 2023 Q4 | 7.41 Million SEK | 33.86% |
| 2023 Q2 | 4.96 Million SEK | -4.32% |
| 2022 Q2 | 6.99 Million SEK | -3.86% |
| 2022 FY | 5.05 Million SEK | -29.03% |
| 2022 Q4 | 5.05 Million SEK | -37.45% |
| 2022 Q1 | 7.27 Million SEK | 2.18% |
| 2022 Q3 | 8.07 Million SEK | 15.5% |
| 2021 Q3 | 7.74 Million SEK | 15.62% |
| 2021 FY | 7.12 Million SEK | -4.49% |
| 2021 Q1 | 6.7 Million SEK | -10.09% |
| 2021 Q2 | 6.69 Million SEK | -0.12% |
| 2021 Q4 | 7.12 Million SEK | -8.02% |
| 2020 Q3 | 7.56 Million SEK | 11.48% |
| 2020 Q4 | 7.45 Million SEK | -1.44% |
| 2020 Q2 | 6.78 Million SEK | 11.85% |
| 2020 Q1 | 6.06 Million SEK | -35.4% |
| 2020 FY | 7.45 Million SEK | -20.62% |
| 2019 Q3 | 7.59 Million SEK | 28.27% |
| 2019 FY | 9.39 Million SEK | 48.85% |
| 2019 Q1 | 6.35 Million SEK | 0.66% |
| 2019 Q2 | 5.92 Million SEK | -6.75% |
| 2019 Q4 | 9.39 Million SEK | 23.63% |
| 2018 Q4 | 6.3 Million SEK | 54.14% |
| 2018 FY | 6.3 Million SEK | 145.68% |
| 2018 Q3 | 4.09 Million SEK | -14.6% |
| 2018 Q2 | 4.79 Million SEK | 118.01% |
| 2018 Q1 | 2.19 Million SEK | -14.39% |
| 2017 Q3 | 4.26 Million SEK | -12.25% |
| 2017 Q2 | 4.86 Million SEK | 30.56% |
| 2017 Q1 | 3.72 Million SEK | 50.14% |
| 2017 FY | 2.56 Million SEK | 3.51% |
| 2017 Q4 | 2.56 Million SEK | -39.83% |
| 2016 FY | 2.48 Million SEK | -73.21% |
| 2016 Q3 | 3.38 Million SEK | -23.13% |
| 2016 Q4 | 2.48 Million SEK | -26.8% |
| 2016 Q2 | 4.4 Million SEK | -43.7% |
| 2016 Q1 | 7.83 Million SEK | -15.42% |
| 2015 Q2 | 3.37 Million SEK | 33.4% |
| 2015 FY | 9.26 Million SEK | 187.67% |
| 2015 Q4 | 9.26 Million SEK | 56.21% |
| 2015 Q3 | 5.92 Million SEK | 75.54% |
| 2015 Q1 | 2.53 Million SEK | -21.36% |
| 2014 Q1 | 5.52 Million SEK | 0.84% |
| 2014 FY | 3.21 Million SEK | -41.21% |
| 2014 Q2 | 2.41 Million SEK | -56.22% |
| 2014 Q4 | 3.21 Million SEK | -18.47% |
| 2014 Q3 | 3.94 Million SEK | 63.34% |
| 2013 Q3 | 6.93 Million SEK | -9.46% |
| 2013 Q2 | 7.66 Million SEK | 38.11% |
| 2013 FY | 5.47 Million SEK | -9.1% |
| 2013 Q4 | 5.47 Million SEK | -21.06% |
| 2013 Q1 | 5.54 Million SEK | -7.91% |
| 2012 Q3 | 9.39 Million SEK | 22.88% |
| 2012 Q1 | 8.55 Million SEK | -4.15% |
| 2012 Q2 | 7.64 Million SEK | -10.64% |
| 2012 Q4 | 6.02 Million SEK | -35.9% |
| 2012 FY | 6.02 Million SEK | -32.54% |
| 2011 Q3 | 10.07 Million SEK | 14.23% |
| 2011 Q4 | 8.92 Million SEK | -11.41% |
| 2011 Q2 | 8.82 Million SEK | 15.15% |
| 2011 FY | 8.92 Million SEK | 68.74% |
| 2011 Q1 | 7.66 Million SEK | 44.82% |
| 2010 Q4 | 5.29 Million SEK | 5.58% |
| 2010 Q3 | 5.01 Million SEK | 5.16% |
| 2010 FY | 5.29 Million SEK | 108.14% |
| 2010 Q1 | 3.97 Million SEK | 56.28% |
| 2010 Q2 | 4.76 Million SEK | 19.96% |
| 2009 Q3 | 2.61 Million SEK | -23.51% |
| 2009 FY | 2.54 Million SEK | -12.8% |
| 2009 Q2 | 3.41 Million SEK | 0.0% |
| 2009 Q4 | 2.54 Million SEK | -2.8% |
| 2008 FY | 2.91 Million SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Acarix AB (publ) | 6.83 Million SEK | -8.393% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 93.884% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 93.884% |
| Arcoma AB | 28.02 Million SEK | 73.551% |
| Bactiguard Holding AB (publ) | 29.64 Million SEK | 74.995% |
| BICO Group AB (publ) | 493.1 Million SEK | 98.497% |
| Boule Diagnostics AB (publ) | 62.4 Million SEK | 88.12% |
| CellaVision AB (publ) | 126.03 Million SEK | 94.118% |
| Clinical Laserthermia Systems AB (publ) | 6.11 Million SEK | -21.226% |
| Chordate Medical Holding AB (publ) | 1.77 Million SEK | -318.596% |
| C-Rad AB (publ) | 64.09 Million SEK | 88.435% |
| Duearity AB (publ) | 4.15 Million SEK | -78.24% |
| Episurf Medical AB (publ) | 3.7 Million SEK | -100.351% |
| Getinge AB (publ) | 6.41 Billion SEK | 99.884% |
| Scandinavian Real Heart AB (Publ) | -1.68 Million SEK | 540.366% |
| Iconovo AB (publ) | -4.86 Million SEK | 252.468% |
| Integrum AB (publ) | 22.36 Million SEK | 66.85% |
| Luxbright AB (publ) | 8000.00 SEK | -92562.5% |
| Mentice AB (publ) | 14.1 Million SEK | 47.44% |
| OssDsign AB (publ) | 4.3 Million SEK | -72.235% |
| Paxman AB (publ) | 19.99 Million SEK | 62.933% |
| Promimic AB (publ) | 330 Thousand SEK | -2146.364% |
| Qlife Holding AB (publ) | 7.29 Million SEK | -1.659% |
| SciBase Holding AB (publ) | 11.91 Million SEK | 37.805% |
| ScandiDos AB (publ) | 22.69 Million SEK | 67.329% |
| Sectra AB (publ) | 36.59 Million SEK | 79.74% |
| Sedana Medical AB (publ) | 42.97 Million SEK | 82.75% |
| Senzime AB (publ) | 20.34 Million SEK | 63.555% |
| SpectraCure AB (publ) | 1.00 SEK | -741299900.0% |
| Stille AB | 66.55 Million SEK | 88.862% |
| Vitrolife AB (publ) | 413 Million SEK | 98.205% |
| Xvivo Perfusion AB (publ) | 141.6 Million SEK | 94.765% |